Archive
Proactive news snapshot: Advanced Oncotherapy, Westminster Group, Faron Pharmaceuticals …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Faron Pharmaceuticals Limited
LON:FARN
Faron Pharmaceuticals is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient’s own immune system. The company’s lead asset bexmarilimab is currently being investigated in Phase I/II clinical trial as a potential therapy for patients with hematological cancers in combination with other standard treatments.
418 stories · page 4 of 5
Oil services giant John Wood Group gushes higher as it says it's confident of return to growth in 2018
A look at some notable movers in London trade on Friday
Faron Pharmaceuticals gains some early understanding of phase III trial data
The company is taking a closer look at the results from its INTEREST study
FTSE 100 ends week on a positive note; ITV is top riser
ITV's trading statement at the AGM gave the broadcaster a hot in the arm
Archive
Proactive news snapshot: Challenger Acquisitions, SDX Energy, Greencoat UK Wind …
A glance at some of the day's highlights from the Proactive Investors newswire
Nanoco Group on the front foot after receiving £1.8mln payment from US partner
A look at some of the top risers and fallers in London on Tuesday
Faron Pharma assesses options after phase III disappointment
CEO, Dr Markku Jalkanen, said he and his team was "incredibly disappointed and surprised" by the results, which were at odds with data garnered from an earlier trial
FTSE 100 closes slightly in red; Shire biggest gainer
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
Rate hike unlikely from May Bank of England policy meeting after recent dull UK data
Aside from the latest Bank of England interest rate decision, the week ahead includes updates from Wm Morrison Supermarkets, Next, BT Group, ITV, and William Hill ...
Archive
Proactive news snapshot: Collagen Solutions, Falcon Oil & Gas, SkinBioTherapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
UKOG slumps while Falcon Oil & Gas advances
A look at some of today's top risers and fallers in London
Investments and investor services
FTSE 100 ends in positive territory, bolstered by miners and weaker pound
The premier UK share index closed up around 24 points at 7,281.
Archive
Proactive news snapshot: W Resources, Sunrise Resources, Learning Technologies …
A glance at some of the day's highlights from the Proactive Investors newswire
Elektron Technology shares rise as it sells Queensgate Nano to Prior Scientific
A look at some of today's top risers and fallers in London
Faron Pharmaceuticals raises £15mln to establish network for Traumakine launch
A placing and subscription at 805p, the closing price yesterday, will bring in a net £14.1mln
FTSE 100 caps comeback week with 60 point rise; FCA gives MPs full report into RBS GRG unit
The blue-chip index rose more than 200 points on the week, bouncing back from the recent shake-out
Archive
Proactive news snapshot: Aminex, Solo Oil, Galileo Resources, Eckoh …
A glance at some of the day's highlights from the Proactive Investors newswire
Kosmos Energy falls as tests at Requin Tigre-1 exploration well in Senegal fail to detect any hydrocarbons
A look at some of the London market's biggest risers and fallers on Monday
Faron establishes second Traumakine manufacturing site as it prepares for commercialisation
The read-out from the recently-completed INTEREST study is due later this half and Faron is getting its house in order should the data come back positive
FTSE 100 succumbs to global profit-taking, closes firmly in red
The UK blue chip index closed down 108.45 points at 7.334, which had been the session low
Archive
Proactive news snapshot: Stratex International, Diversified Gas & Oil, Keywords Studios …
A glance at some of the day's highlights from the Proactive Investors newswire
Spectra Systems counting the coins as it says 2017 will be ahead of expectations
Some of the main news-driven risers and fallers on Thursday...
Faron extends patent protection for Clevegen cancer immunotherapy
"The grant of this patent serves to protect the innovative mechanism underlying Clevegen, which will be important in realising the potential our second wholly-owned product promises"
Investments and investor services
FTSE 100 closes in red but broadcaster ITV shines
Footsie finished down over 43 points at 7,490, while FTSE 250 was also lower - down around 58 points at 20,185.
Archive
Proactive news snapshot: Porta Communications, Telit Communications, Concepta ...
A glance at some of the day's highlights from the Proactive Investors newswire
Sopheon tops London risers as it raises 2017 guidance
Some of the main news-driven risers and fallers in London on Monday...
Faron Pharmaceuticals drug receives fast-track designation from US regulator
This accelerated review is designed to get drugs to areas of unmet medical need
FTSE 100 closes higher, just, with miners in support
The FTSE 100, dragged higher by the miners, got off to a strong start today, but closed juts about six points higher
Archive
Proactive news snapshot: Empresaria Group, Directa Plus, ImmuPharma …
A glance at some of the day's highlights from the Proactive Investors newswire
Faron Pharmaceuticals looks to Clevegen opportunity after Traumakine disappointment
Clevegen has shown no toxicologically relevant changes in any subject in dose escalation studies.
Empresaria surges after a reassuring trading statement
Premaitha is given a fillip by permission to appeal against High Court's decision on patent dispute
Faron Pharmaceuticals makes more headway with the US regulator
Chief executive Dr Markku Jalkanen said he was pleased with the latest approval from the Food & Drug Administration
Investments and investor services
FTSE 100 closes in the red as sterling booms
“If he intended it, Treasury Secretary Steven Mnuchin has done a first class job of whacking the dollar,” declared Neil Wilson at ETX Capital. .
Archive
Proactive news snapshot: Horse Hill, Kromek Group, Base Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Fusion Antibodies up another 30% after posting a 35% leap on Monday's AIM debut
A look at some of the biggest risers and fallers in London on Tuesday
Faron Pharmaceuticals receives clinical trial green light in second indication for lead drug
Traumakine is being tested for safety and efficacy in patients with multi-organ failure - this is a potential second indication for the drug
FTSE 100 closes in positive territory but off session highs
The UK blue chip index closed around seven points higher at 7,544, below the day’s peak of 7,563
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
Investments and investor services
FTSE 100 finishes in the red as BoE keeps rates on hold
FTSE 100 closed down over 48 points at 7,448., while FTSE 250 shed over 55 to 20,006
Archive
Proactive news snapshot: Hurricane Energy, Cadence Minerals, Flying Brands …
A glance at some of the day's highlights from the Proactive Investors newswire
Vela Technologies flying high after investee company bags deal with American Airlines
Vela Technologies PLC flying high after investee company bags deal with American Airlines
Faron Pharmaceuticals completes recruitment for phase III trials of its ARDS treatment
300 patients have now been recruited across Europe for the trial which is looking at whether Traumakine can reduce all-cause mortality in acute respiratory distress syndrome sufferers
Investments and investor services
FTSE 100 closes higher as miners gain and sterling slides
The FTSE 100 closed the day higher, as the weak pound helped, while other European indices lagged
Archive
Proactive news snapshot: Rose Petroleum, LEKOIL, Diversified Gas & Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Broker downgrades send Royal Mail and Babcock International lower
Some of the biggest risers and fallers in London on Friday.
Faron Pharmaceuticals hires chief commercial officer ahead of drug launch
Dr Juhana Heinonen will join the business in January from AstraZeneca
Investments and investor services
FTSE 100 slides as Trump impeachment fears resurface
The Teflon president faced another test of his lucky rabbit's foot's effectiveness
Archive
Proactive news snapshot: Rose Petroleum, Ortac Resources, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
SSE rallies despite HSBC trimming its price target
SSE may have rallied, but Centrica remained down in the dumps, after HSBC trimmed its price target for the British Gas owner to 190p from 202p.
Faron Pharmaceuticals' £10mln fundraiser will accelerate progress
Shares are being issued at 800p each, which is a modest 2% discount to Wednesday’s closing price
FTSE 100 closes firmly in positive territory as sterling slides
The FTSE 100 rose to within a couple of points of 7,500 after US markets opened higher
Archive
Proactive news snapshot: Hurricane Energy, AFC Energy, Canadian Overseas Petroleum …
A glance at some of the day's highlights from the Proactive Investors newswire
Greencore Group dives following product recall in the US
The US Food and Drug Administration's sampling found some Listeria monocytogenes in Greencore's sandwiches
Faron Pharmaceuticals' lead drug gets significant vote of confidence from UK regulator
The Medicines and Healthcare Products Regulatory Agency has given Faron drug,Traumakine, a Promising Innovative Medicines designation
FTSE 100 closes firmly higher as weak pound gives it a boost
FTSE 100 closed over 66 points higher at 7,438 with budget carrier easyJet the top flyer
Archive
Proactive news snapshot: Synairgen, Silence Therapeutics, LoopUp Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Cyber security firm Shearwater soars as chairman increases holding
Sports Direct, Barratt Developments, Ryanair and EasyJet were among Wednesday's early market movers.
Faron Pharma primed for a pivotal period in its development
The company is more advanced than many of its AIM compatriots, with a drug undergoing Phase III clinical trials
FTSE 100 closes lower as traders continue to fret about North Korea
FTSE 100 closed down 18.79 at 7,354, while the FTSE 250 lost over 74 points at 19,652.
Archive
Sports Direct chairman faces the boot at AGM on busy day of updates from housebuilders
Sports Direct’s AGM and earnings from housebuilders will take centre stage on Wednesday
Archive
Proactive news snapshot: 88 Energy, Sound Energy, Sunrise Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Faron Pharma gets a boost as FDA says can use outside US trial data for Traumakine license application
Dr Markku Jalkanen, Faron's CEO, said: "This important feedback potentially speeds up the regulatory approval process in the US and brings us one step closer to delivering Traumakine to patients in the world's largest pharmaceutical market“
Archive
Barrage of builders to update in week ahead with Brexit concerns remaining key
Week ahead includes updates from a raft of housebuilders, including Barratt Developments, Berkeley Group and Bovis Homes, plus trading news from Halfords Group, and the latest European Central Bank Council meeting
Archive
Proactive news snapshot – Porta Communications, S & U, FairFX…
Some of the day's highlights from the Proactive newswire...
Petrofac gets Oman contract boost; Anglo African Oil & Gas up on acquisition completion
A look at some of the biggest risers and faller in London today ...
Faron Pharma to provide drug compassionate use of drug; data monitors green light study as it moves into its final few months
The study, codenamed INTEREST, should be wrapped up in the fourth-quarter
FTSE 100 receives boost from US jobless figures
The blue-chip index closed at 7,512, up 37 points on the day and 143 on the week
Faron Pharma weak on profit-taking after an uninspiring report on ongoing phase III trials
Analyst Julie Simmonds at broker Panmure Gordon said: “No negative or positive read through on the likely outcome of the trial can be made from the statement”
FTSE 100 firm but off highs as New York makes dull early progress
With around an hour and a half of trading to go in London, the FTSE 100 was up about 11 points at 7,308, holding off the day’s peak of 7,322
Archive
Proactive news round-up: Lombard Risk Management, Acal, Symphony Environmental Technologies …
A glance at some of the stories on the Proactive newswire today
Lombard Risk Management surges after raising guidance
Lombard Risk provided further evidence that its turnaround plan is gaining momentum
Drug developer Faron Pharmaceuticals to appoint two industry heavyweights to the board
Dr Gregory Brown and John Poulos bring with them a breadth and depth of industry experience
FTSE 100 closes down as May wins MP backing for election
Although it has been an up and down day for the Footsie, it has rarely strayed far from last night's closing level
Archive
Proactive news round-up: SDX Energy, Motif Bio, Sound Energy…
A glance at some of the stories on the Proactive newswire today
ASA Resource plunges as its finds evidence of corruption at Zimbabwean asset
On the plus side, the board is pretty certain there have been no thefts of gold from the gold room at FRGM, or shipments of gold ore to China.
Faron teams up with University of Birmingham for Clevegen liver cancer clinical program
The two will work together to develop and initiate a liver cancer program testing Clevegen in clinical trials
FTSE 100 down 164 points on snap election news; pound hits 10-week high
The UK prime minister has announced a snap general election for 8 June
Archive
Proactive News round-up: Obtala, Sabien Technology, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Long wait to supply Airbus is over for Hardide
Some of the largest risers and fallers in London at 3.15pm
Drug developer Faron Pharmaceuticals' annual results statement charts a year of major landmarks
Traumakine, used to treat acute respiratory distress syndrome, is undergoing a phase III clinical trial with results expected in the second half.
Archive
Have a break, have a Brexit
Article 50 will be triggered on Wednesday but there is still a lot of horse trading to be done over the coming months before Britain's departure from the EU is settled
ValiRx and Faron highlight different sides of pharma funding
Some the largest rises and fall at 3pm: ValiRx, Faron, Jersey Oil
FTSE stocks mark record highs with Wall St as Trump boosts construction, commodity stocks
FTSE 100 stocks, just like Wall Street, defied soothsayers’ prognoses that investors didn’t much like a threadbare speech to Congress from US President Donald Trump overnight, and pledged their vote to his spending ambitions as record heigh
Archive
Webis sales rise not enough to offset margin concerns
Some the largest share price rises and fall in London at 3pm: Webis, Wey Education, ValiRx
Faron Pharmaceuticals raises £5mln in premium placing
The new funds will be used to expand the pre-clinical and early-clinical development of the company’s immuno-oncology drug, Clevegen
EQTEC steps on gas as parent converts loan
Some of the largest rises and falls in London at 3.15pm: EQTEC, Goldplat, Feedback
Faron Pharmaceuticals drug Traumakine goes into phase II clinical trials for second major indication
The drug is currently undergoing a phase III study in patients with acute respiratory distress syndrome after delivering some remarkable results earlier in its development.
Investments and investor services
FTSE closes flat as Unilever holds market back
The FTSE 100 ended flat on Monday as Unilever shares sank in the wake of Kraft Heinz saying it had abandoned its proposed merger which would have been one of the biggest in corporate history
Archive
Proactive news highlights: featuring Corero Network Security, Redx Pharma, Faron Pharmaceuticals and more…
Corero off to fast start in 2017 with contract win; Redx Pharma unveils plans to raise up to £14.9mln; Faron Pharma is ‘excited’ for the coming year; plus much more…
Faron Pharmaceuticals 'excited' about key year as it gears up for successful completion of clinical trial
Faron believes its drug, Traumakine, could revolutionise the intensive care treatment for patients with acute respiratory distress syndrome – a lung condition that currently has a high death rate.
Four drug stocks to watch in phase III next year
2017 could be a big year for these four lesser-known junior drug developers
Small Cap highlights: Sareum leads Monday’s stand-out small cap biotech stocks
Sareum, Faron, WideCells, Abzena and Ergomed were among Monday's small cap highlights
Recruitment starts in Japan for pivotal trial for Faron's Traumakine
The Japanese Phase III trial will significantly increase the total number of patients in Traumakine pivotal studies